Observation
Institutions move slower than the world they're supposed to protect.
The FDA approved a drug on falsified data and now cannot easily revoke it because patients have built their lives around access. Ketamine and designer psychoactives flood campuses undetected by standard screening because the detection technology hasn't kept pace with the chemistry. Women directors lack access to funding not because gatekeepers changed their minds, but because the funding architecture was built before the problem was visible. The pattern is consistent: by the time an institution recognizes what needs to change, the change has already happened everywhere else, and removing the old permission structure costs more than granting it did.